In surgical or medical procedures, a pneumatic tourniquet serves as a medical device temporarily limiting blood circulation to a specific limb. This apparatus comprises an inflatable cuff enveloping the upper arm or thigh, linked to a device capable of inflating and deflating the cuff.
The global pneumatic tourniquet market was valued at US$ 389.7 Million in 2022 and is anticipated to reach US$ 696.8 Million by the end of 2030 with a CAGR of 7.6% from 2023 to 2030 (forecast period).
Upon inflation of the cuff, blood flow to the targeted area is transiently halted due to the compression of blood vessels within the limb. This cessation of blood flow proves valuable in controlling bleeding during the procedure, affording the surgeon a clear and uncontaminated workspace. Typically, the cuff is inflated to a pressure level that effectively restricts blood flow without causing permanent harm to the surrounding tissues.
Orthopaedic surgeries, such as joint replacements or repairs, as well as various other procedures affecting the hand or foot, often incorporate the use of pneumatic tourniquets. However, it’s crucial to acknowledge that these devices come with inherent risks. Prudent employment under meticulous supervision is essential to mitigate potential outcomes like nerve or muscle injuries, along with the risk of ischemia, which entails a deficiency of blood flow to the tissues.
Increasing Prevalence of Chronic Diseases and Rise in Surgical Procedures to Boost Pneumatic Tourniquet Market
The market for pneumatic tourniquets is primarily driven by the rise in surgical procedures being carried out on a global scale. The World Health Organisation (WHO) predicts that by 2030, there will be 234 million surgical procedures done worldwide. Over the projected period, this is expected to increase demand for pneumatic tourniquets.
The increased incidence of chronic diseases is another factor boosting the market for pneumatic tourniquets. By 2030, 1.7 billion people are anticipated to be affected by chronic diseases, according to the WHO. As a result, more surgical procedures are likely to be conducted, which is anticipated to raise demand for pneumatic tourniquets.
The rise in trauma occurrences is another factor driving the pneumatic tourniquet market. By 2030, the WHO predicts that there will be 35 million incidents of trauma. Over the projection period, this is anticipated to increase demand for pneumatic tourniquets.
To increase access to healthcare services, governments are investing in healthcare infrastructure. Because of this, there is an increased need for medical equipment, such as pneumatic tourniquets, to support the increasing number of surgical procedures being carried out.
North America to Spearhead the Global Pneumatic Tourniquet Market
North America is the fastest-growing segment in the pneumatic tourniquet market due to several factors, including:
The escalating demand for surgical interventions is closely linked to the ageing demographic and the heightened prevalence of chronic illnesses. This surge in surgical necessities has inevitably led to an augmented requirement for surgical procedures. In this context, pneumatic tourniquets, renowned for their capacity to temporarily obstruct blood flow to specific regions, are poised to experience heightened demand as a direct consequence.
Anticipated strides in technology, particularly within the domain of digital tourniquet technology, are projected to precipitate broader acceptance of pneumatic tourniquets across medical facilities. These technological enhancements encompass features such as adjustable pressure settings and automated safety mechanisms, which are expected to catalyze their adoption.
Orthopedic injuries are assuming a more prominent role, particularly with the prevalence of sprains and fractures in the North American region. In orthopedic procedures, the incorporation of pneumatic tourniquets to curtail blood loss and mitigate complications is poised to significantly contribute to the expansion of the market.
The upward trajectory of healthcare expenses in North America is driving the augmented usage of innovative medical equipment, pneumatic tourniquets being a prominent example. Hospitals and healthcare establishments are increasingly inclined to invest in equipment that enhances patient outcomes while concurrently mitigating the risk of complications.
The presence of favorable reimbursement policies for medical devices within the North American healthcare landscape is expected to be a pivotal driver in encouraging healthcare practitioners to embrace pneumatic tourniquets. These policy measures serve as a mechanism to alleviate the financial burden associated with the acquisition of such devices, thereby fostering their integration within medical practices.
Companies operating in the global pneumatic tourniquet market have adopted several growth strategies to expand their market share and increase their revenue. Some of the significant players operating in the market are Bohua Medical, Hpm, Hangzhou Zhengda, DS MAREF, Stryker, Ulrich Medical, SMEF, Huifeng Medical,VBM, AneticAid, Hema Medical, Zimmer, D & D, Smith+Nephew, DeRoyal Industries, CoNextions Medical, etc.
Enterprises operating within the pneumatic tourniquet sector employ a spectrum of strategies to foster competitiveness and innovation:
Partnerships and Collaborations: Businesses forge alliances with fellow enterprises, research institutions, or medical experts, enabling them to harness collective strengths and resources to attain shared objectives. An illustrative instance is the collaboration between CoNextions Medical and Smith+Nephew, unveiled in January 2022. By synergizing CoNextions Medical’s advanced tourniquet technology with Smith+Nephew’s prowess in orthopaedic surgery, the aim is to elevate patient outcomes.
Product Development and Launches: Enterprises allocate resources to research and development (R&D) endeavours to craft novel products or enhance existing ones. This strategy sets them apart from competitors and augments their market share. Noteworthy is DeRoyal Industries, a medical device manufacturer, which introduced the VascuSeal Vascular Occlusion Device—a pneumatic tourniquet system—in September 2021. This innovative device deploys pneumatic technology to occlude blood flow during surgical procedures, engendering superior patient outcomes and diminished complications.
Geographical Expansion: Businesses may expand their operational horizons to access untapped customer segments or diversify revenue streams. This trajectory mandates meticulous market analysis and a profound grasp of each location’s unique demands. An embodiment of this approach lies in Zimmer Biomet, a musculoskeletal healthcare leader, which unveiled intentions in June 2021 to extend its manufacturing facilities in Ireland. This expansion equips the company to address the escalating demand for its tourniquet systems in the European market.
Acquisitions and Mergers: The acquisition or merger with other enterprises can bestow a competitive edge and a fortified market stance. Such manoeuvres facilitate entry into fresh technologies, markets, and talent reservoirs.